We recently published a list of These 10 Stocks Are On Fire Right Now. In this article, we are going…
Tag: Pharmaceuticals
Biodexa Pharmaceuticals sees cash runway into 1Q26
As of May 29, 2025, the Company had access to the following cash resources: Cash at bank $5.7M; Cash in…
Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target
On Tuesday, May 27, an analyst from Truist Securities initiated coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy…
ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) has unveiled promising early results from its Phase 1b trial of ORIC-944, a novel PRC2 inhibitor,…
Accretion Pharmaceuticals IPO listing today. Check GMP ahead of debut
Accretion Pharmaceuticals, a Gujarat-based pharma manufacturer, concluded its Rs 29.75 crore SME IPO on May 16. The issue, priced between…
Acadia Pharmaceuticals price target raised to $19 from $17 at Oppenheimer
Oppenheimer raised the firm’s price target on Acadia Pharmaceuticals (ACAD) to $19 from $17 and keeps a Perform rating on…
Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now?
We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are…
GSK to buy liver disease drug from Boston Pharmaceuticals for up to $2 billion
GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm…
Accretion Pharmaceuticals IPO opens for subscription: Price band, GMP among key details to know
Accretion Pharmaceuticals has opened its initial public offering (IPO) for subscription today, May 14. The IPO, which is set to…